FMP
Vor Biopharma Inc.
VOR
NASDAQ
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
1.71 USD
0.03 (1.75%)
About
ceo
Dr. Robert Ang M.B.A., M.D., MBBS
sector
Healthcare
industry
Biotechnology
website
https://www.vorbio.com
exchange
NASDAQ
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge...
CIK
0001817229
ISIN
US9290331084
CUSIP
929033108
Address
100 Cambridgepark Drive
Phone
617 655 6580
Country
US
Employee
168
IPO Date
Feb 5, 2021
Summary
CIK
0001817229
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
929033108
ISIN
US9290331084
Country
US
Price
1.71
Beta
-0.36
Volume Avg.
318.51k
Market Cap
116.65M
Shares
-
52-Week
1.62-5.7
DCF
-0.06
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.98
P/B
-
Website
https://www.vorbio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest VOR News
It looks like there's no news available.
